09.13.10
InHealth Awards Grants to Duke and Northwestern
The Washington, D.C.-based Institute for Health Technology Studies, or InHealth, has awarded two follow-on grants totaling more than $830,000 to research teams at Northwestern University and Duke University.
Northwestern investigators will receive $240,000 to study opportunities for improving the U.S. Food and Drug Administration’s 510(k) product review process for medical devices. The work builds on previous InHealth-funded research that for the first time documented in detail the medical technology development process.
Duke researchers will receive $600,000 during the course of three years to focus on the lifetime benefits of implantable devices, including replacement knees and hips, and cardiac pacemakers. This research will add to the Duke team’s previously published analyses of the shorter-term impacts of total knee and total hip replacement procedures.
“Evidence-based policy is at the center of the new healthcare landscape, placing even more importance on measuring the effects of medical technology,” said Martyn Howgill, InHealth’s executive director.
Since its founding in 2004, InHealth has invested more than $11 million in research-related activities at U.S. universities.
The Washington, D.C.-based Institute for Health Technology Studies, or InHealth, has awarded two follow-on grants totaling more than $830,000 to research teams at Northwestern University and Duke University.
Northwestern investigators will receive $240,000 to study opportunities for improving the U.S. Food and Drug Administration’s 510(k) product review process for medical devices. The work builds on previous InHealth-funded research that for the first time documented in detail the medical technology development process.
Duke researchers will receive $600,000 during the course of three years to focus on the lifetime benefits of implantable devices, including replacement knees and hips, and cardiac pacemakers. This research will add to the Duke team’s previously published analyses of the shorter-term impacts of total knee and total hip replacement procedures.
“Evidence-based policy is at the center of the new healthcare landscape, placing even more importance on measuring the effects of medical technology,” said Martyn Howgill, InHealth’s executive director.
Since its founding in 2004, InHealth has invested more than $11 million in research-related activities at U.S. universities.